
After decades of lymphedema, breast cancer survivor Nora Ambros finds relief through robot-assisted microsurgery at Hackensack University.

After decades of lymphedema, breast cancer survivor Nora Ambros finds relief through robot-assisted microsurgery at Hackensack University.

Paper Describes Successful Genetic Testing Program Offered at Sheila R. Veloz Breast Center

During her radiation treatments, Sister Monica Marcinak found grace, humor and deep compassion among fellow patients and caregivers facing cancer together.

For patients with pancreatic cancer, this is a guide to the basics you need to know about this disease.

This patient guide explains gastrointestinal stromal tumors, covering diagnosis, treatment options, targeted therapies and practical care tips.

Supportive care with ESAs or danazol alongside Jakafi helps myelofibrosis patients with anemia manage symptoms and maintain effective treatment doses.

The FDA granted orphan drug designation to the investigational therapy MNV-201 for myelodysplastic syndrome, a serious, age-related blood disorder.

I view Breast Cancer Awareness Month as a time to share hope, connection, and stories that remind others life after cancer is possible.

Dr. Anjana Pillai explains that staging liver cancer involves assessing tumor size, spread, and vessel involvement to guide treatment.

When reflecting on the Japanese art of kintsugi, one can find inspiration during a cancer journey, as CURE columnist Chester Freeman explained.

Dr. Anjana Pillai explains liver cancer types, risk factors, and prevention, stressing early screening for high-risk patients with liver disease.

Addressing spirituality and religion can potentially help patients with gynecologic cancers, researchers have found.

After treatment for follicular lymphoma, I reflect on how cancer, retirement, and loss reshaped my sense of normal and what life looks like now.

Brittney Nichols discussed the emotional and physical side effects of lung cancer treatment, as well as feelings of isolation in newly diagnosed patients.

The FDA granted fast track designation to NG-350A for the treatment of patients with mismatch repair-proficient locally advanced rectal cancer.

A study found exercise after treatment boosts cancer survival, prompting experts to call for structured movement as a standard part of survivorship care.

Patients with advanced renal cell carcinoma whose disease has progressed on first-line therapies may benefit from the combination of Fruzaqla and Tyvyt.

Patients living with myelofibrosis who also experience anemia may see meaningful improvements in blood counts when treated with Vonjo.

Dr. Anjana Pillai highlights Liver Cancer Awareness Month’s role in promoting liver health, dispelling myths and encouraging early detection and care.

Thoughts on life, multiple myeloma, architecture and Douglas Adams.

CURE spoke with Betsy Hamlin, who was treated with Keytruda Qlex in a clinical trial after being diagnosed with melanoma.

The FDA granted breakthrough therapy designation to sonrotoclax for adults with relapsed or refractory mantle cell lymphoma, based on phase 1/2 data.

Dr. Komal Jhaveri says Breast Cancer Awareness Month should move beyond pink ribbons to drive early detection, research and equitable care.

I was sitting in my oncologist's office, listening to her explain my treatment plan, when a strange thought crossed my mind: this feels familiar.

While Breast Cancer Awareness Month raises funds and awareness, for survivors, it can painfully remind them of all they’ve endured.

The challenges of being diagnosed with a rare cancer are real, but so is the strength that comes from thriving through it.

Dr. Evan Garfein explains how 3D printing and tissue-engineered implants could make breast reconstruction safer and less taxing on the body.

Brittney Nichols highlights the need for early detection and stresses that lung cancer is not only caused by smoking; anyone can develop the disease.

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

CURE spoke with Dr. Komal Jhaveri about the findings of the EMBER-3 clinical trial.